EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery of RNA Biomarkers for Prostate Cancer Using Cross-Platform Transcriptomics

Wieke C H Visser iD, Hans de Jong iD, Frank P Smit, Jolly Shrivastava, Jason C Poole, William P J Leenders, Willem J G Melchers iD, Peter F A Mulders, Jack A Schalken

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252211907 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Wieke C H Visser und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Product Development, Mdxhealth BV, 6534 AT Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Biomarkers, Tumor, Gene Expression Profiling. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microarray and Single-Molecule Molecular Inversion Probe (smMIP)-based targeted RNA sequencing are two RNA profiling platforms for identifying disease-associated biomarkers. The microarray uses a GeneChip array with oligonucleotide probes to measure expression levels across thousands of genes, while smMIPs capture and quantify RNA transcripts and transcript variants via next-generation sequencing. To evaluate the strengths and weaknesses of both platforms, a comparative gene expression profiling study was conducted using RNA samples from 52 prostate tissues (normal, benign prostatic hyperplasia (BPH) and various prostate cancer (PCa) grades). Of all genes covered by both platforms, only 35% of the expression levels aligned, with 45% showing discrepancies. Both platforms identified the same 17 genes as potential PCa biomarkers. Microarray analysis identified an additional 253 genes that were not covered or not identified by smMIP technology, while smMIP technology identified eight markers not covered or not identified in the microarray core gene analysis, including fusion genes and splice variants. For high-grade prostate cancer (HG-PCa), the smMIP-method identified 8 markers, and the microarray identified 17 markers, with FOLH1, FAP and CLDN3 being common across both platforms. The choice of RNA expression analysis technology depends on research objectives; microarray technology is useful for the evaluation of a wide range of genes but has low throughput. In contrast, smMIP-based RNA sequencing enables sensitive analysis with minimal RNA in a medium- to high-throughput setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsBiomarkers, TumorGene Expression ProfilingMaleHumansTranscriptomeOligonucleotide Array Sequence AnalysisGene Expression Regulation, NeoplasticHigh-Throughput Nucleotide SequencingSequence Analysis, RNAProstatic HyperplasiaRNA

Stichwörter der Autor:innen

biomarkersgene expression profilingmicroarrayprostate cancer (PCa)single-molecule molecular inversion probes (smMIPs)

Substanzen

Biomarkers, TumorRNA

Autor:innen und Institutionen

  • Department of Product Development, Mdxhealth BV, 6534 AT Nijmegen, The Netherlands.
  • Department of Product Development, Mdxhealth, Irvine, CA 92618, USA.
  • Predica Diagnostics, 6525 ED Nijmegen, The Netherlands.
  • Department of Medical Microbiology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
  • Department of Urology, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.

ORCID-Profile: Wieke C H Visser, Hans de Jong, Willem J G Melchers

Zitieren

APA

Visser, W. C. H., de Jong, H., Smit, F. P., Shrivastava, J., Poole, J. C., Leenders, W. P. J., Melchers, W. J. G., Mulders, P. F. A., & Schalken, J. A. (2024). Discovery of RNA Biomarkers for Prostate Cancer Using Cross-Platform Transcriptomics. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252211907

Vancouver

Visser WCH, de Jong H, Smit FP, Shrivastava J, Poole JC, Leenders WPJ, et al. Discovery of RNA Biomarkers for Prostate Cancer Using Cross-Platform Transcriptomics. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252211907

BibTeX
@article{Visser2024,
  author = {Visser, Wieke C H and de Jong, Hans and Smit, Frank P and Shrivastava, Jolly and Poole, Jason C and Leenders, William P J and Melchers, Willem J G and Mulders, Peter F A and Schalken, Jack A},
  title = {Discovery of RNA Biomarkers for Prostate Cancer Using Cross-Platform Transcriptomics},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252211907}
}
Kostenlos starten →